Eventide Asset Management, LLC Compass Therapeutics, Inc. Transaction History

Eventide Asset Management, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 13, 2023	SELL	$2.55 - $5.41 $421,535 - $894,316	-165,308 Reduced 15.02%	935,091 $4.7 Million
Q3 2022 Nov 14, 2022	BUY	$1.9 - $3.37 $2.09 Million - $3.71 Million	1,100,399 New	1,100,399 $2.51 Million

91.9M

Ticker CMPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 101,285,000
Market Cap $139M
Description
Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Eventide Asset Management, LLC with notifications on news.